Add time:09/02/2019         Source:sciencedirect.com

As part of our on-going effort to explore the role of dopamine receptors in drug addiction and identify potential novel therapies for this condition, we have a identified a series of N-(4-(4-phenyl piperazin-1-yl)butyl)-4-(thiophen-3-yl)benzamide D3 ligands. Members of this class are highly selective for D3 versus D2, and we have identified two compounds (13g and 13r) whose rat in vivo IV pharmacokinetic properties that indicate that they are suitable for assessment in in vivo efficacy models of substance use disorders.

We also recommend Trading Suppliers and Manufacturers of 3-(4-BUTYL-PHENYL)-2-MERCAPTO-3H-QUINAZOLIN-4-ONE (cas 133032-36-7). Pls Click Website Link as below: cas 133032-36-7 suppliers